Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says

Idenix Pharmaceuticals, the developer of an experimental hepatitis C drug, is in talks to find a partner to create a combination treatment to fight the virus, CEO Ron Renaud said.
Bloomberg